Cocrystal Pharma
COCP
22 hedge funds and large institutions have $1.02M invested in Cocrystal Pharma in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
0.61% less ownership
Funds ownership: 7.36% → 6.75% (-0.61%)
4% less capital invested
Capital invested by funds: $1.06M → $1.02M (-$41.1K)
8% less funds holding
Funds holding: 24 → 22 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$7.61K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$2.69K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.54K |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
+$320 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
-$84.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$14.2K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$11.3K |
| 4 |
Renaissance Technologies
New York
|
-$893 |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$750 |
COCP Hedge Fund Activity: Q2 2025 in Review
22 of the 7,616 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q2 2025, worth a combined $1.02M — down 3.9% from $1.06M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of COCP and 1 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 5 added.
The largest buyer was Susquehanna International Group, adding an estimated $10.3K. The largest seller was Neuberger Berman Group, exiting entirely with an estimated $84.2K sold.
- 22 institutional investors held Cocrystal Pharma (COCP) as of Q2 2025, down from 24 in Q1 2025.
- Funds reported $1.02M of Cocrystal Pharma stock for Q2 2025, down 3.9% quarter-over-quarter.
- 1 fund opened new Cocrystal Pharma positions in Q2 2025 and 3 closed out, a net change of -2 holders.
- The largest Cocrystal Pharma buyer in Q2 2025 was Susquehanna International Group, an estimated $10.3K added.
- The largest Cocrystal Pharma seller in Q2 2025 was Neuberger Berman Group, an estimated $84.2K sold.
Based on aggregated 13F filings for Q2 2025.